Does TAFASITAMAB-CXIX Cause Enterococcal bacteraemia? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Enterococcal bacteraemia have been filed in association with TAFASITAMAB-CXIX. This represents 0.7% of all adverse event reports for TAFASITAMAB-CXIX.
5
Reports of Enterococcal bacteraemia with TAFASITAMAB-CXIX
0.7%
of all TAFASITAMAB-CXIX reports
0
Deaths
0
Hospitalizations
How Dangerous Is Enterococcal bacteraemia From TAFASITAMAB-CXIX?
Of the 5 reports.
Is Enterococcal bacteraemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAFASITAMAB-CXIX. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TAFASITAMAB-CXIX Cause?
Disease progression (218)
Lymphoma (158)
Off label use (126)
Death (53)
Drug ineffective (39)
Blood lactate dehydrogenase increased (34)
Diffuse large b-cell lymphoma (32)
Malignant neoplasm progression (30)
Neutropenia (30)
Polyneuropathy (29)
What Other Drugs Cause Enterococcal bacteraemia?
CYCLOPHOSPHAMIDE (139)
RITUXIMAB (116)
MYCOPHENOLATE MOFETIL (95)
PREDNISONE (91)
METHOTREXATE (83)
DOXORUBICIN (81)
VINCRISTINE (81)
DEXAMETHASONE (76)
TACROLIMUS (75)
FLUDARABINE (74)
Which TAFASITAMAB-CXIX Alternatives Have Lower Enterococcal bacteraemia Risk?
TAFASITAMAB-CXIX vs TAFINLAR
TAFASITAMAB-CXIX vs TAFLUPROST
TAFASITAMAB-CXIX vs TAGRAXOFUSP-ERZS
TAFASITAMAB-CXIX vs TAHOR
TAFASITAMAB-CXIX vs TALAZOPARIB